IPHARMA is a contract research organization specialized in conducting clinical trials of investigational drugs in the Russian Federation and the EAEU.
-
Drug registration
IPHARMA is a member of ChemRar High-Tech Center group of companies and an accredited partner of Skolkovo Innovation Center.
Quick facts 2012-2019
#1 CRO in Russia according to the results of 2018.
Leading positions on the market of Russian innovative drugs according to ACTO analytical report for 2013 - 2018.
95+
110+
65+
370+
1180+
5100+
10
Products in clinical pipeline
Protocols written
Regulatory approvals
Clinical sites
Healthy volunteers enrolled
Patients enrolled
Original drugs filed for registration
IPHARMA continue to hold a series of webinars on Youtube channel.
We share our knowledge and experience in clinical research with a wide audience by means of free webinars in witch we discuss the current issues of drug development and safety.
Advantages of working with IPHARMA
1. Leading positions on the market of Russian innovative drugs according to ACTO analytical report for 2013 - 2018.
2. Opportunities for drug localization, investments, and market access.
3. Full cycle of drug development: formulation, batches, QC, preclinical, clinical.
4. Medical and PV expertise with access to top scientists and KOLs.
5. Quality management systems and experienced staff.
IPHARMA contacts
5, Nobel street, Skolkovo Innovative Centre, Moscow, 143026, Russia
Tel.: +7 (495) 276-11-43
Fax: +7 (495) 276-11-47
E-mail: info@ipharma.ru
